[Mutational Profiling of Pediatric Myeloid Leukemia Subtypes without Clinically Significant Chromosomal Aberrations]

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Identifying molecular and genetic markers is crucial for diagnosing, prognosing, and selecting therapies for hematological malignancies.
• While over 40% of pediatric acute myeloid leukemia (AML) cases have distinct cytogenetic aberrations, approximately 20% present with a normal karyotype (NK-AML).

Purpose of the Study:

• To analyze the mutational profiles of leukemic cells in pediatric AML cases with a normal karyotype.
• To identify novel AML-specific molecular and genetic markers for improved diagnostics and treatment.

Main Methods:

• Massive parallel sequencing was used to analyze the coding regions of 26 genes involved in AML pathogenesis.
• Leukemic cells from 34 pediatric AML cases with normal karyotypes were examined.

Main Results:

• Somatic mutations were identified in genes crucial for intracellular signaling pathways, including CEBPA, ETV, IDH1, JAK2, and NRAS.
• Rare genetic variants were also found in CUX1, FLT3, TET2, PTPN11, and NUP98 genes.

Conclusions:

• The identified mutations and variants contribute to understanding the mechanisms of malignant cell transformation in leukemogenesis.
• These findings may lead to the discovery of novel diagnostic and therapeutic targets for pediatric NK-AML.